Navigation Links
Pitt-led research provides insight into development of congenital circulatory defects
Date:7/8/2008

PITTSBURGHUniversity of Pittsburgh-led researchers could provide new insight into how two common congenital circulatory problemsaortic arch deformity and arteriovenous malformations (AVMs)develop in humans, as reported in the June 15 edition of Developmental Biology.

Led by Beth Roman, an assistant professor of biological sciences in Pitt's School of Arts and Sciences, the team created the first complete published description of how aortic arch vessels form and, in a separate finding also described in the paper, determined that AVMswherein an artery fuses with a vein and diverts blood flowcan form as a result of combined genetic and physiological factors and not solely because of genetics.

The team created the aortic arch vessel development model from zebrafish embryos, which develop similarly to humans but more rapidly. In humans, the aortic arch vessels contribute to several of the body's major arteries and often develop improperly, resulting in a wide range of vascular defects. The model could allow for a better understanding of the genetic program that governs aortic arch development, and therefore help in predicting abnormalities and determining when and how to intervene.

From the model, the team discovered that the gene unc45a plays a critical and previously unknown role in the formation of the aortic arch vesselsand that mutations in that gene can result in AVMs. In zebrafish harboring the mutation, two aortic arch vessels failed to connect properly to the body's major artery, the dorsal aorta. Instead, dead-end vessels formed then swelled with blood until they touched and fused with a nearby vein.

AVMs typically form embryonically, but the particular AVMs Roman's team observed did not form in the absence of blood flow, indicating that they were not genetically hardwired, she said. Additionally, AVM formation was inconsistent in terms of location on the aortic arch vessel, Roman said. The mutants randomly develo
'/>"/>

Contact: Morgan Kelly
mekelly@pitt.edu
412-624-4356
University of Pittsburgh
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Leading Plastic Surgeons Reveal Revolution in Stem Cell Research Has its Roots in Beverly Hills Plastic Surgery
2. Orange County research program aims to improve severe trauma survival rates
3. Autism Research Institute Launches Mobile Website
4. Jefferson researchers show antibody to breast cancer-secreted protein blocks metastasis
5. Wake Forest researchers say popular fish contains potentially dangerous fatty acid combination
6. New research reveals ultraviolet light therapy is as beneficial for darker skin as lighter skin
7. Ivy Foundation Funds New Brain Cancer Research Consortium : $3M Stage I Project Aims to Improve Personalized Medicine for Patients
8. The Henry H. Kessler Foundation Appoints New Vice President for Research and Strengthens Relationship With Current Research Luminary
9. The Foundation for Accelerated Vascular Research Grants $150,000 Wylie Scholar Award for Blood Vessel Research
10. Nuvo Research and Paladin announce amendments to Pennsaid and Pennsaid Plus agreements
11. GRAS Proudly Announces Photometrica Version 2.0. Hailed as a Brilliant Solution for More Productive Astronomical Research by Those Engaged in Photometry Using the Global-Rent-a-scope Telescope Systems

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)... A jury of 8 people in the Wester...woman $2,300,000 in pain and suffering for a medic...mes Tallman and Alicia Nocera of Thomas E. Crenney... the plaintiff, Vita Monestersky and against the U...ency total abdominal hysterectomy at age 18. , ...
(Date:11/8/2009)...ation,s largest network of Hispanic health advocat...eform in 2009 ,, WASHINGTON, Nov. 7 /PRNewswir...entatives showed they have heard the voice of Amer...re for America Act. Now the Senate must deliver, w...care reform," said Dr. Jane L. Delgado, President ...
(Date:11/8/2009)...alls for Swift Passage of H.R. 3961 to Secure the ...wswire-USNewswire/ -- Statement Attributable to: J...Association. ,, (Logo: http://www.newscom.com...hails the passage of the House health reform bill,...ients and physicians and calls for swift passage o...
(Date:11/8/2009)...ealth Care Vote Shows Who Sides With Working Famil..., Nov. 8 On the heels o...esentatives for a good, balanced health care refor...ing of how our state,s U.S. representatives voted ... Act. ,, The legislation, which passed Saturda...
(Date:11/7/2009)...SHINGTON, Nov. 7 Karen ...urance Plans (AHIP), released the following statem...alth plans strongly support comprehensive health c...sion by proposing a complete overhaul of how healt...posed guaranteed coverage, elimination of pre-exis...
Breaking Medicine News(10 mins):Health News:Pennsylvania Jury Awards $2.3 Million to Fayette County Woman in Medical Malpractice Case 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2Health News:Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge 2Health News:AHIP Statement on House Passage of H.R. 3962 2
...ns Growthink to Raise $2 Million Dollars in ...S, June 18 Growthink, the leading Investment,Bank...ging and Middle,Market Enterprises, announced toda... by the Food, Beverage,Pharmaceutical and Health S...
...uray,Incorporated (Nasdaq: ARAY ), a global leade...t its president and chief executive officer, Euan ...Jefferies Healthcare,Conference on Thursday, June ...any,s Web site at, http://www.accuray.com . The we...
...itment to Securing Confidential Customer ...SKING RIDGE, N.J. and NEWPORT BEACH, Calif., June ...re technology solutions,serving nearly half of the...ybertrust Enterprise Certification., By meeting t...
... University, Gentag,Inc., and Science Applications...combined forces to develop a non-invasive method f...rs agreed to combine their,respective intellectual...ting products could eliminate the need for finger,...
...e Integrase(TM) assays used to study ... FRANCISCO, Calif., June 18 Monogram,Biosciences,...ompany has,signed an agreement with Gilead Science...tients for study,enrollment and help select drugs ...
...new Lumax 540 technologies together with BIOTRONIK...d patient management that,provides daily protectio... BIOTRONIK GmbH & Co KG, the pioneer in wireless ...es, which,includes implantable cardioverter defibr...
Other Medicine News:Health News:Pop! Technology Goes Growthink 2Health News:Accuray Incorporated's CEO to Speak at Jefferies Second Annual Healthcare Conference 2Health News:TriZetto Maintains Prestigious Verizon Business Security Certification for Sixth Consecutive Year 2Health News:TriZetto Maintains Prestigious Verizon Business Security Certification for Sixth Consecutive Year 3Health News:TriZetto Maintains Prestigious Verizon Business Security Certification for Sixth Consecutive Year 4Health News:No More Needles? Georgetown University Teams with Gentag and SAIC to Develop New Glucose Sensor Technology with Wireless Connection to Cell Phones 2Health News:No More Needles? Georgetown University Teams with Gentag and SAIC to Develop New Glucose Sensor Technology with Wireless Connection to Cell Phones 3Health News:Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies 2Health News:Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies 3Health News:Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies 4Health News:Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies 5Health News:Tomorrow's care today: Lumax 540 cardiac devices launched at Cardiostim 2Health News:Tomorrow's care today: Lumax 540 cardiac devices launched at Cardiostim 3
(Date:11/6/2009)...Newswire-FirstCall/ -- Recession in domestic and i...r Allied Healthcare Products in the first quarter ..., Sales declines pushed Allied into a loss for th... $745,000, or negative 9 cents per share, compared...0, or 3 cents per share. ,, Sales fell about 2...
(Date:11/6/2009)...Newswire/ -- Trius Therapeutics, Inc. announced to...Form S-1 with the U.S. Securities and Exchange Com...c offering of shares of its common stock. All shar...will be offered by the Company. ,, Credit Suiss...ing manager, Piper Jaffray & Co. is acting as ...
(Date:11/6/2009)...6 Repossessions and liquidations o...d quarter of 2009 declined as compared to similar ...ement,s NasTrac Quarterly Index (NQI). The figure...both repossessions and orderly liquidations, also ...ction and printing equipment, offering mixed news ...
Breaking Medicine Technology:Recession Continues to Depress Sales at Allied Healthcare Products 2Recession Continues to Depress Sales at Allied Healthcare Products 3Recession Continues to Depress Sales at Allied Healthcare Products 4Recession Continues to Depress Sales at Allied Healthcare Products 5Recession Continues to Depress Sales at Allied Healthcare Products 6NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 2NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 3NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 4LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 1LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 2LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 3LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 4SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 1SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 2SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 3SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 4SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 5PDL BioPharma Elects Barry Selick to Its Board of Directors 53479 1PDL BioPharma Elects Barry Selick to Its Board of Directors 53479 2
... New product recently approved by FDA for long-ter...n; data demonstrate,first nebulized formoterol fum...o dry powder formoterol, enhanced patient quality ... (May 20, 2007) – Data presented at the,Inte...ety (ATS),demonstrate that Perforomist™ (for...
...BRIDGE, Mass.--(BUSINESS WIRE)--May 16, 2007 - Glo... biopharmaceutical,company, announced today that t...nted Fast Track designation for its novel histone,...rapy of,previously treated peripheral T-cell lymph...hat it has reached an agreement with the,FDA under...
Other Medicine Technology:Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 2Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 3Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 4Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 5Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 6Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 7Gloucester Pharmaceuticals Receives Fast Track Designation for,Romidepsin in Peripheral T-Cell Lymphoma 2Gloucester Pharmaceuticals Receives Fast Track Designation for,Romidepsin in Peripheral T-Cell Lymphoma 3
Dodick-Kammann Nucleus Chopper
Chang Phaco Chopper
Denman Brown Nucleus Cracker
Forceps Epilation Angled End B510.10 3.5"
Medicine Products: